Ventas, Inc.
VTRAPI behind this page
VTR Q4 2025 request
Playground key active
/api/financials?ticker=VTR&year=2025&quarter=4
Pick an endpoint and run the request.
Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Operating Lease Lease Income | 359,469 | 373,602 | -3.8% |
Show Product Lines breakouts |
|||
| NNN | 132,713 | 157,403 | -15.7% |
| Outpatient medical and research portfolio (OM&R) | 226,756 | 216,199 | +4.9% |
Show Business Segments breakouts |
|||
| NNN · Operating Segments | 132,713 | 157,403 | -15.7% |
| Outpatient medical and research portfolio (OM&R) · Operating Segments | 226,756 | 216,199 | +4.9% |
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Management Service | 3.8 | 3.8 | -0.0% |
| Third-party capital management revenues | 4,322 | 4,339 | -0.4% |
| Third-party capital management revenues · Corporate Non Segment | 3,543 | 3,588 | -1.3% |
| Third-party capital management revenues · Outpatient medical and research portfolio (OM&R) | 779 | 751 | +3.7% |
| Interest And Other Income | 7,877 | 8,305 | -5.2% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 7,877 | 8,305 | -5.2% |
| Revenue | 1,566,017 | 1,287,057 | +21.7% |
Show Business Segments breakouts |
|||
| NNN · Operating Segments | 132,713 | 157,403 | -15.7% |
| Outpatient medical and research portfolio (OM&R) · Operating Segments | 227,535 | 216,950 | +4.9% |
Show — breakouts |
|||
| Revenue | 1,185,999 | 896,360 | +32.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 19,770 | 16,344 | +21.0% |
| Interest Expense | 154,468 | 153,206 | +0.8% |
| Depreciation And Amortization | 352,723 | 308,772 | +14.2% |
| Direct Costs Of Leased And Rented Property Or Equipment | 935,786 | 739,506 | +26.5% |
Show Product Lines breakouts |
|||
| NNN | 3,000 | 4,206 | -28.7% |
| Outpatient medical and research portfolio (OM&R) | 77,639 | 73,617 | +5.5% |
Show Business Segments breakouts |
|||
| NNN · Operating Segments | 3,000 | 4,206 | -28.7% |
| Outpatient medical and research portfolio (OM&R) · Operating Segments | 77,639 | 73,617 | +5.5% |
Show — breakouts |
|||
| Direct Costs Of Leased And Rented Property Or Equipment | 855,147 | 661,683 | +29.2% |
| Direct Costs Of Leased And Rented Property Or Equipment | 855,147 | 661,683 | +29.2% |
| Cost Of Other Property Operating Expense | 1,610 | 1,551 | +3.8% |
| General & Administrative | 41,008 | 41,434 | -1.0% |
| Gains Losses On Extinguishment Of Debt | 53 | 15 | +253.3% |
| Business Combination Acquisition Related Costs | -6,008 | 4,226 | -242.2% |
| Total Costs & Expenses | 1,489,731 | 1,287,565 | +15.7% |
| Income Before Taxes | 76,286 | -508 | +15116.9% |
| Income Loss From Equity Method Investments And Remeasurement Gain On Equity Interest In Acquiree | -7,727 | 6,969 | -210.9% |
| Gain Loss On Disposition Of Real Estate | 3,311 | 6,727 | -50.8% |
| Income Tax Expense (Benefit) | 1,122 | 45,539 | -97.5% |
| Net Income | 72,992 | 58,727 | +24.3% |
Show Equity Components breakouts |
|||
| Parent | 70,202 | 56,835 | +23.5% |
| Retained Earnings | 70,202 | 56,835 | +23.5% |
| Net Income Loss Attributable To Noncontrolling Interest | 2,790 | 1,892 | +47.5% |
| Net Income Loss Available To Common Stockholders Basic | 70,202 | 56,835 | +23.5% |
| Income Loss From Continuing Operations Per Basic Share | 0.15 | 0.14 | +7.1% |
| EPS (Basic) | 0.15 | 0.14 | +7.1% |
| Income Loss From Continuing Operations Per Diluted Share | 0.16 | 0.14 | +14.3% |
| EPS (Diluted) | 0.14 | 0.13 | +7.7% |
| Comprehensive Income | 68,141 | 61,782 | +10.3% |
| Wtd Avg Shares (Basic) | 5,510 | 3,079 | +79.0% |
| Wtd Avg Shares (Diluted) | 6,223 | 3,581 | +73.8% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 741,067 | 897,850 | -17.5% |
| Non-Current Assets | |||
| Operating Lease Right-of-Use Assets | 295,838 | 308,019 | -4.0% |
| Goodwill | 1,046,072 | 1,044,915 | +0.1% |
Show Business Segments breakouts |
|||
| NNN | 319,569 | — | — |
| Outpatient medical and research portfolio (OM&R) | 466,967 | — | — |
| SHOP | 259,536 | — | — |
| Deferred Tax Assets | 2,797 | 1,931 | +44.8% |
| Total Assets | 27,591,945 | 26,186,906 | +5.4% |
Show Legal Entity breakouts |
|||
| Fonds Immobilier Groupe Maurice, S.E.C. · Variable Interest Entity Primary Beneficiary | 1,822,300 | 1,779,762 | +2.4% |
| NHP/PMB L.P. · Variable Interest Entity Primary Beneficiary | 656,813 | 728,457 | -9.8% |
| Other identified VIEs · Variable Interest Entity Primary Beneficiary | 1,469,659 | 1,447,381 | +1.5% |
Show Real Estate Properties breakouts |
|||
| Unconsolidated Properties | 9,991,116 | 9,813,724 | +1.8% |
| Other Assets | |||
| Investment Building And Building Improvements | 30,872,598 | 28,717,990 | +7.5% |
| Finite Lived Intangible Assets Gross | 1,680,567 | 1,558,751 | +7.8% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Above Market Leases | 120,178 | 124,515 | -3.5% |
| In-place and other lease intangibles | 1,560,389 | 1,434,236 | +8.8% |
| Real Estate Investment Property At Cost | 36,170,552 | 33,696,781 | +7.3% |
| Real Estate Investment Property Net | 24,126,933 | 22,600,545 | +6.8% |
Show Geography breakouts |
|||
| CA | 2,783,873 | 2,719,078 | +2.4% |
| GB | 205,060 | 190,629 | +7.6% |
| US | 21,138,000 | 19,690,838 | +7.3% |
| Secured Notes And Loans Receivable Net | 143,913 | 144,872 | -0.7% |
| Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures | 617,571 | 626,122 | -1.4% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| All other · Unconsolidated Properties | 581 | 601 | -3.3% |
| Atrium Health & Wake Forest Joint Venture · Unconsolidated Properties | 39,809 | 36,881 | +7.9% |
| Pension Fund Joint Venture · Unconsolidated Properties | 6,200 | 11,939 | -48.1% |
| R&I JV [Member] · Unconsolidated Properties | 282,512 | 309,499 | -8.7% |
| The Fund [Member] · Unconsolidated Properties | 288,469 | 267,202 | +8.0% |
| Ventas Investment Management platform · Unconsolidated Properties | 577,181 | 588,640 | -1.9% |
| Real Estate Investments | 24,888,417 | 23,371,539 | +6.5% |
| Escrowdepositsandrestrictedcash | 45,070 | 59,383 | -24.1% |
Show Fair Value By Measurement Basis breakouts |
|||
| Carrying Reported Amount Fair Value Disclosure | 45,070 | 59,383 | -24.1% |
| Estimate Of Fair Value Fair Value Disclosure | 45,070 | 59,383 | -24.1% |
| Assets Of Disposal Group Including Discontinued Operation | 42,993 | 18,625 | +130.8% |
Show Business Segments breakouts |
|||
| NNN | 22,188 | — | — |
| Outpatient Medical Buildings And Other | 468 | 13 | +3500.0% |
| SHOP | 20,337 | 18,612 | +9.3% |
| Other Assets | 825,529 | 792,663 | +4.1% |
| Non-Current Liabilities | |||
| Interest Payable Current And Noncurrent | 143,104 | 143,345 | -0.2% |
| Accounts Payable And Accrued Liabilities Current And Noncurrent | 1,240,820 | 1,152,306 | +7.7% |
| Deferred Tax Liabilities | 23,409 | 8,150 | +187.2% |
| Total Liabilities | 14,630,983 | 15,047,081 | -2.8% |
Show Legal Entity breakouts |
|||
| Fonds Immobilier Groupe Maurice, S.E.C. · Variable Interest Entity Primary Beneficiary | 1,151,437 | 1,121,659 | +2.7% |
| NHP/PMB L.P. · Variable Interest Entity Primary Beneficiary | 235,245 | 286,030 | -17.8% |
| Other identified VIEs · Variable Interest Entity Primary Beneficiary | 467,665 | 410,721 | +13.9% |
Show Real Estate Properties breakouts |
|||
| Unconsolidated Properties | 6,228,827 | 6,168,639 | +1.0% |
| Long-Term Debt | 13,011,016 | 13,522,551 | -3.8% |
| Other Liabilities | |||
| Longtermdebtandshorttermborrowings | 13,011,016 | 13,522,551 | -3.8% |
| Operating Lease Liability | 208,602 | 218,003 | -4.3% |
| Liabilities Of Disposal Group Including Discontinued Operation | 4,032 | 2,726 | +47.9% |
Show Business Segments breakouts |
|||
| NNN | 1,116 | — | — |
| Outpatient Medical Buildings And Other | 130 | 568 | -77.1% |
| SHOP | 2,786 | 2,158 | +29.1% |
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | 375,154 | 310,229 | +20.9% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 114,482 | 109,809 | +4.3% |
Show Partner Type Of Partners Capital Account breakouts |
|||
| General Partner | 260,672 | 200,420 | +30.1% |
| Stockholders' Equity | |||
| Common Stock | 118,732 | 109,119 | +8.8% |
| Additional Paid In Capital Common Stock | 19,976,183 | 17,607,482 | +13.5% |
| Accumulated Other Comprehensive Income | -39,851 | -33,526 | -18.9% |
| Retained Earnings | -7,527,777 | -6,886,653 | -9.3% |
| Treasury Stock Value | -34 | -25,155 | +99.9% |
| Total Stockholders' Equity | 12,527,253 | 10,771,267 | +16.3% |
Show Real Estate Properties breakouts |
|||
| Unconsolidated Properties | 3,256,420 | 3,062,405 | +6.3% |
| Minority Interest | 58,555 | 58,329 | +0.4% |
Show Real Estate Properties breakouts |
|||
| Unconsolidated Properties | 505,869 | 582,678 | -13.2% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 12,585,808 | 10,829,596 | +16.2% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -39,851 | -33,526 | -18.9% |
| Additional Paid In Capital | 19,976,183 | 17,607,482 | +13.5% |
| Common Stock | 118,732 | 109,119 | +8.8% |
| Noncontrolling Interest | 58,555 | 58,329 | +0.4% |
| Parent | 12,527,253 | 10,771,267 | +16.3% |
| Retained Earnings | -7,527,777 | -6,886,653 | -9.3% |
| Treasury Stock Common | -34 | -25,155 | +99.9% |
| Total Liabilities & Equity | 27,591,945 | 26,186,906 | +5.4% |
| Land | 2,962,738 | 2,775,790 | +6.7% |
| Construction In Progress Gross | 358,811 | 336,231 | +6.7% |
| Accumulateddepreciationandamortization | -12,043,619 | -11,096,236 | -8.5% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Other Amortization Of Deferred Charges | 9,844 | 7,796 | +26.3% |
| Stock-Based Compensation | 6,318 | 4,647 | +36.0% |
| Straight Line Rent | -10,068 | 1,375 | -832.2% |
| Extinguishment Of Debt Gain Loss Net Of Tax | 53 | 15 | +253.3% |
| Other Tax Expense Benefit | -2,148 | -46,022 | +95.3% |
| Equity Method Investment Dividends Or Distributions | 7,292 | 4,659 | +56.5% |
| Other Non-Cash Items | 3,246 | 25,081 | -87.1% |
| Increase Decrease In Other Operating Assets | -16,168 | 5,041 | -420.7% |
| Increase Decrease In Interest Payable Net | 29,638 | 30,620 | -3.2% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 21,763 | -326 | +6775.8% |
| Net Cash from Operations | 471,663 | 373,641 | +26.2% |
| Investing Activities | |||
| Payments To Acquire Loans Receivable | -69 | -4,668 | +98.5% |
| Proceeds From Sale Of Real Estate Heldforinvestment | 54,392 | 53,698 | +1.3% |
| Proceeds From Sale And Collection Of Loans Receivable | 39,383 | 374 | +10430.2% |
| Payments To Develop Real Estate Assets | -96,340 | -82,668 | -16.5% |
| Payments To Acquire Equity Method Investments | -15,628 | -14,294 | -9.3% |
| Proceeds From Insurance Settlement Investing Activities | 2,071 | 19 | +10800.0% |
| Net Cash from Investing | -428,722 | -1,536,214 | +72.1% |
| Financing Activities | |||
| Proceeds From Repayments Of Lines Of Credit | 0 | -952 | +100.0% |
| Proceeds From Issuance Of Debt | 523,647 | 107,985 | +384.9% |
| Repayments Of Other Debt | -128,111 | -81,447 | -57.3% |
| Payments Of Financing Costs | -4,928 | -1,194 | -312.7% |
| Proceeds From Issuance Of Common Stock | 279,460 | 1,114,306 | -74.9% |
| Payments Of Dividends Common Stock | -225,684 | -188,957 | -19.4% |
| Proceeds From Minority Shareholders | 0 | 57 | -100.0% |
| Payments To Minority Shareholders | -5,086 | -8,160 | +37.7% |
| Proceeds From Stock Options Exercised | 65,212 | 15,569 | +318.9% |
| Proceeds From Payments For Other Financing Activities | -2,868 | 1,246 | -330.2% |
| Net Cash from Financing | 499,856 | 956,201 | -47.7% |
| Supplemental | |||
| Income Taxes Paid | -1,056 | 427 | -347.3% |
| Other Cash Flow | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 542,797 | -206,372 | +363.0% |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 789 | -2,092 | +137.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 786,137 | 957,233 | -17.9% |
| Transfer Of Investments | 1,549 | 32,623 | -95.3% |
| Noncash Or Part Noncash Acquisition Other Assets Acquired1 | 1,335 | 11,784 | -88.7% |
| Noncash Or Part Noncash Acquisition Deferred Income Tax Liabilities Assumed | 73,702 | 21,613 | +241.0% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.